Citations

Mayo Clinic

Showing 10 of 108572 citations.

Initial versus Subsequent Injury and Illness and Temporal Trends Among Professional Hockey Players
Martin, Chelsea , Lieb, Allison, Tokish, John M. , Shanely, Ellen, Kluzek, Stefan , Collins, Professor Gary S. , Tokish, John, Collins, Gary , Bullock, Garrett S.

International Journal of Sports Physical Therapy | February 1, 2024 | Volume: 19 | Issue: 2 | Pages: No page available

10.26603/001c.92309 | PMID 38313661 Get It

Background Research is limited investigating injuries/illness incidence among National Hockey League (NHL) players. This study sought to establish injury/illness incidence, initial versus subsequent injury risk among NHL players, and determine temporal trends of injury and illness incidence. Hypothesis Variations in injury incidence by body region, and initial versus subsequent injury would be observed among positions. Study Design Retrospective cohort study Methods Publicly available data were utilized. NHL players 18 years or older between 2007-2008 to 2018-2019 were included. Injury and illness was stratified by position and body segment. Incidence rate (IR), and initial versus subsequent injury and illness risk ratios were calculated. Temporal trends were reported. Results Nine thousand, seven-hundred and thirty four injuries and illnesses were recorded. Centers had the highest overall IR at 15.14 per 1000 athlete game exposures (AGEs) (95%CI:15.12-15.15) and were 1.4 times more likely to sustain a subsequent injury compared to other positions. The groin/hip/thigh was the most commonly injured body region with an IR of 1.14 per 1000 AGEs (95%CI:1.06-1.21), followed by the head/neck (0.72 per 1000 AGEs, 95%CI:0.66-0.78). Combined injury and illness IR peaked in 2009-2010 season at 12.01 (95%CI: 11.22-12.79). The groin/hip/thigh demonstrated peak incidence during the 2007-2008 season (2.53, 95%CI:2.17-2.90); head/neck demonstrated a peak incidence in 2010-2011 season (Overall: 1.03, 95%CI:0.81-1.26). Injuries reported as ‘lower body’ increased over time. Conclusions Positional differences were observed; centers demonstrated the highest overall IR, and subsequent injury risk. Injury by body region was similar to previous literature. Head/neck and concussion decreased over time supporting rule changes in body checking and visor wear. Clinicians should be aware that ‘lower body’ injuries increased over time; therefore, injuries to the groin/hip/thigh or knee are likely underreported. Level of Evidence Level 3
Perceived Impact of Society for Research on Nicotine and Tobacco Health Equity Network’s Pre-conference Workshops on Attendees’ Professional Development
Jacobs, Wura , Jackson, Asti , Martinez, Sydney A. , Addicott, Merideth A. , Denlinger-Apte, Rachel , Mithi, Vita , Patten, Christi A. , Castro, Yessenia , Tan, Andy S L , Denlinger-Apte, Rachel L , Mithi, Vita , Patten, Christi , Kypriotakis, George

Nicotine and Tobacco Research | February 1, 2024 | Volume: 26 | Issue: 7 | Pages: 959-960

10.1093/ntr/ntae018 | PMID 38297962 Get It

Abstract PR09: Functional and clinical characterization of hypomorphic missense variants in the BRCA2 cancer predisposition gene
Abozaid, Mohamed , Munankarmy, Amik , Rao, Tara, Couch, Ronan E. , Persons, Benjamin R., Pesaran, Tina , Huang, Huaizhi , Hu, Chunling , Na, Jie , Abozaid, Mohamed, Lumby, Carolyn A. , Lyra, Paulo C. , Polley, Eric C. , Karam, Rachid , Yadav, Siddhartha , Monteiro, Álvaro N.A. , Boddicker, Nicholas , Domchek, Susan M. , Richardson, Marcy E , Couch, Fergus J.

Cancer Research | February 1, 2024 | Volume: 84 | Issue: 3_Supplement_1 | Pages: PR09-PR09

10.1158/1538-7445.advbc23-pr09 Get It

Abstract Many germline BRCA2 missense variants of uncertain significance (VUS) remain to be clinically classified as pathogenic or benign. Here we identify 70 missense VUS in the DNA binding domain (DBD) of BRCA2 that partially reduced homologous recombination DNA repair activity of the protein in a homology directed DNA repair cell-based assay. CRISPR/cas9-based knockin of these variants reduced cell survival of haploid cells and conferred increased sensitivity to the PARP inhibitor Olaparib. Sequence alignment analysis found that the variants were highly conserved across species from pufferfish to human. Structural analysis showed that these variants are located predominantly in unstructured regions of the DBD. Case-control association studies showed that the hypomorphic variants conferred moderate risks of breast (OR:2.85; 95%CI:1.43-5.88) and ovarian cancer (OR:3.37; 95%CI:1.30-8.54) that were significantly different from risks associated with known pathogenic and benign variants. Cumulative lifetime risks of breast and ovarian cancer among carriers were estimated at 25% and 4.7%, respectively. Age at diagnosis of breast cancer among hypomorphs carriers was 55 years of age as opposed to 48 years of age for carriers of pathogenic variants. In addition, the combination of functional and other genetic data in an ACMG/AMP-like variant classification model reclassified 39 variants as likely pathogenic. This novel group of low penetrance missense variants further calibrate BRCA2 variant classification methods and have significant implications for the management of variant carriers. Citation Format: Huaizhi (Gilbert) Huang, Chunling Hu, Jie Na, Mohamed Abozaid, Amik Munankarmy, Tara Rao, Carolyn A. Dunn Lumby, Paulo Cilas Morais Lyra, Ronan E. Couch, Benjamin R. Persons, Eric C. Polley, Rachid Karam, Tina Pesaran, Siddhartha Yadav, Alvaro N.A. Monteiro, Nicholas J. Boddicker, Susan M. Domchek, Marcy E. Richardson, Fergus J. Couch. Functional and clinical characterization of hypomorphic missense variants in the BRCA2 cancer predisposition gene [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr PR09.
Teaming in Graduate Medical Education: Ward Rounds and Beyond
Nataraj, Neela , Tome, June , Ratelle, John T. , Tome, June , Nataraj, Neela

Journal of Medical Education and Curricular Development | February 1, 2024 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/23821205231225588 | PMID 38304280 Get It

Teamwork in graduate medical education (GME) is often hindered in clinical learning environments where discontinuity among residents, supervisors, and other health care professionals is typical. Teaming is a conceptual approach to teamwork in dynamic environments with constantly changing team members and goals. Teaming is built on principles of project management and team leadership, which together provide an attractive strategy for addressing teamwork challenges in GME. Indeed, teaming is now a requirement of the Accreditation Council for Graduate Medical Education Clinical Learning Environment Review program. However, many clinician-educators and leaders may be unfamiliar with teaming and how to integrate it into their GME programs. In this article, the teaming framework is described with a specific example of how it can be applied to improve hospital ward rounds, a common setting of teamwork breakdown. The goal of this article is to educate and encourage GME leaders as they learn new ways to implement teaming to improve patient care and education in their programs.
A prediction model for response to immune checkpoint inhibition in advanced melanoma
Duin, Isabella A.J. van , Verheijden, Rik J. , Diest, P. J. van , El‐Sharouni, Mary‐Ann, Eertwegh, Alfonsus Johannes Maria van den, Groot, Jan Willem B. de , Aarts, Maureen J.B. , Berkmortel, Franchette W.P.J. van den , Blank, Christian U. , Piersma, Djura , Rijn, Rozemarijn S. van, Veldt, Astrid A.M. van der , Vreugdenhil, Gerard , Boer, Marion A. M. Stevense‐den, Boers‐Sonderen, Marye J. , Kapiteijn, Ellen , Elias, Sjoerd G. , van Duin, Isabella A J , van Diest, Paul J , Blokx, Willeke A.M. , Verhoeff, Joost J.C. , Leiner, Tim , Not, Olivier J. van , Haanen, John B A G , Hospers, Geke A.P. , Wouters, Michel W.J.M. , Suijkerbuijk, Karijn P.M.

International Journal of Cancer | February 1, 2024 | Volume: 154 | Issue: 10 | Pages: 1760-1771

10.1002/ijc.34853 | PMID 38296842 Get It

AbstractPredicting who will benefit from treatment with immune checkpoint inhibition (ICI) in patients with advanced melanoma is challenging. We developed a multivariable prediction model for response to ICI, using routinely available clinical data including primary melanoma characteristics. We used a population‐based cohort of 3525 patients with advanced cutaneous melanoma treated with anti‐PD‐1‐based therapy. Our prediction model for predicting response within 6 months after ICI initiation was internally validated with bootstrap resampling. Performance evaluation included calibration, discrimination and internal–external cross‐validation. Included patients received anti‐PD‐1 monotherapy (n = 2366) or ipilimumab plus nivolumab (n = 1159) in any treatment line. The model included serum lactate dehydrogenase, World Health Organization performance score, type and line of ICI, disease stage and time to first distant recurrence—all at start of ICI—, and location and type of primary melanoma, the presence of satellites and/or in‐transit metastases at primary diagnosis and sex. The over‐optimism adjusted area under the receiver operating characteristic was 0.66 (95% CI: 0.64–0.66). The range of predicted response probabilities was 7%–81%. Based on these probabilities, patients were categorized into quartiles. Compared to the lowest response quartile, patients in the highest quartile had a significantly longer median progression‐free survival (20.0 vs 2.8 months; P < .001) and median overall survival (62.0 vs 8.0 months; P < .001). Our prediction model, based on routinely available clinical variables and primary melanoma characteristics, predicts response to ICI in patients with advanced melanoma and discriminates well between treated patients with a very good and very poor prognosis.
Acute Ascending Flaccid Paralysis in a Healthy 16-year-old
Penfold, Michael , Starnes, Keith , Corredor, Margarita , Penfold, Michael P , Starnes, Donnie Keith , Penfold, Michael P.

Pediatrics in Review | February 1, 2024 | Volume: 45 | Issue: 2 | Pages: 96-99

10.1542/pir.2021-005164 | PMID 38296775 Get It

A stepwise approach to coronary artery stenting in acute type A aortic dissection
Singh, Kuljit , Niranjan, Selva, Hibbert, Benjamin , Taramasso, Maurizio , Hibbert, Benjamin

Catheterization and Cardiovascular Interventions | February 1, 2024 | Volume: 103 | Issue: 4 | Pages: 560-564

10.1002/ccd.30964 | PMID 38297982 Get It

AbstractWe present three cases of acute coronary obstruction postsurgical repair of type A aortic dissection, which were successfully treated with percutaneous coronary intervention. We describe a step‐by‐step approach to performing percutaneous coronary intervention in selective cases of coronary obstruction related to type A aortic dissection.
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
Wiste, Heather J. , Bornhorst, Joshua A. , Li, Yan , Graff‐Radford, Jonathan , Vemuri, Prashanthi , Lowe, Val J. , Jack, Clifford R. , Petersen, Ronald C. , Algeciras‐Schimnich, Alicia , Algeciras-Schimnich, Alicia , Figdore, Daniel J. , Jack, Clifford R , Vemuri, Prashanthi , Bornhorst, Joshua , Bateman, Randall J. , Knopman, David S.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | February 1, 2024 | Volume: 16 | Issue: 1 | Pages: No page available

10.1002/dad2.12545 | PMID 38304322 Get It

AbstractINTRODUCTIONThis study evaluated the performance of the Lumipulse plasma beta‐amyloid (Aβ) 42/40 and pTau181 compared to other assays to detect an abnormal amyloid‐positron emission tomography (PET).METHODSPlasma samples from cognitively unimpaired (N = 179) and MCI/AD dementia (N = 36) individuals were retrospectively evaluated. Plasma Aβ42/40 and pTau181 were measured using the Lumipulse and Simoa immunoassays. An immunoprecipitation mass spectrometry (IP‐MS) assay for plasma Aβ42/40 was also evaluated. Amyloid‐PET status was the outcome measure.RESULTSLumipulse and IP‐MS Aβ42/40 exhibited the highest diagnostic accuracy for detecting an abnormal amyloid‐PET (areas under the curve [AUCs] of 0.81 and 0.84, respectively). The Lumipulse and Simoa pTau181 assays exhibited lower performance (AUCs of 0.74 and 0.72, respectively). The Simoa Aβ42/40 assay demonstrated the lowest diagnostic accuracy (AUC 0.57). Combining Aβ42/40 and pTau181 did not significantly improve performance over Aβ42/40 alone for Lumipulse (AUC 0.83) or over pTau181 alone for Simoa (AUC 0.71)DISCUSSIONThe Lumipulse Aβ42/40 assay showed similar performance to the IP‐MS Aβ42/40 assay for detection of an abnormal amyloid‐PET; and both assays performed better than the two p‐tau181 immunoassays. The Simoa Aβ42/Aβ40 assay was the least accurate at predicting an abnormal amyloid‐PET status.Highlights Lumipulse plasma Aβ42/Aβ40 AUC for abnormal amyloid‐PET detection was 0.81. This performance was comparable to previously reported IP‐MS and higher than Simoa. Performance of Alzheimer's disease blood biomarkers varies between assays.
Diabetes screening outcomes in youth presenting for paediatric weight management: A report of the Paediatric Obesity Weight Evaluation Registry
Kumar, Seema , King, Eileen, Binns, Helen J. , Christison, Amy L. , Cuda, Suzanne , Joseph, Madeline , Kirk, Shelley, Christison, Amy , Yee, Jennifer K.

Pediatric Obesity | February 1, 2024 | Volume: 19 | Issue: 4 | Pages: No page available

10.1111/ijpo.13102 | PMID 38296252 Get It

SummaryObjectiveRising prevalence of obesity has led to increased rates of prediabetes and diabetes mellitus (DM) in children. This study compares rates of prediabetes and diabetes using two recommended screening tests (fasting plasma glucose [FPG] and haemoglobin A1c [HbA1c]).Study DesignData were collected prospectively from 37 multi‐component paediatric weight management programs in POWER (Paediatric Obesity Weight Evaluation Registry).ResultsFor this study, 3962 children with obesity without a known diagnosis of DM at presentation and for whom concurrent measurement of FPG and HbA1c were available were evaluated (median age 12.0 years [interquartile range, IQR 9.8, 14.6]; 48% males; median body mass index 95th percentile [%BMIp95] 134% [IQR 120, 151]). Notably, 10.7% had prediabetes based on FPG criteria (100–125 mg/dL), 18.6% had prediabetes based on HbA1c criteria (5.7%–6.4%), 0.9% had DM by FPG abnormality (≥126 mg/dL) and 1.1% had DM by HbA1c abnormality (≥6.5%). Discordance between the tests was observed for youth in both age groups (10–18 years [n = 2915] and age 2–9 years [n = 1047]).ConclusionThere is discordance between FPG and HbA1c for the diagnosis of prediabetes and DM in youth with obesity. Further studies are needed to understand the predictive capability of these tests for development of DM (in those diagnosed with prediabetes) and cardiometabolic risk.
Human myofiber‐enriched aging‐induced lncRNA FRAIL1 promotes loss of skeletal muscle function
Miller, Matthew J. , Gries, Kevin J. , Marcotte, George R. , Ryan, Zachary, Strub, Matthew D. , Arendt, Bonnie K., Dasari, Surendra , Adams, Christopher M. , Lanza, Ian R , Adams, Christopher M , Kunz, Hawley , Ebert, Scott M. , Lanza, Ian R.

Aging Cell | February 1, 2024 | Volume: 23 | Issue: 4 | Pages: No page available

10.1111/acel.14097 | PMID 38297807 Get It

Abstract The loss of skeletal muscle mass during aging is a significant health concern linked to adverse outcomes in older individuals. Understanding the molecular basis of age‐related muscle loss is crucial for developing strategies to combat this debilitating condition. Long noncoding RNAs (lncRNAs) are a largely uncharacterized class of biomolecules that have been implicated in cellular homeostasis and dysfunction across a many tissues and cell types. To identify lncRNAs that might contribute to skeletal muscle aging, we screened for lncRNAs whose expression was altered in vastus lateralis muscle from older compared to young adults. We identified FRAIL1 as an aging‐induced lncRNA with high abundance in human skeletal muscle. In healthy young and older adults, skeletal muscle FRAIL1 was increased with age in conjunction with lower muscle function. Forced expression of FRAIL1 in mouse tibialis anterior muscle elicits a dose‐dependent reduction in skeletal muscle fiber size that is independent of changes in muscle fiber type. Furthermore, this reduction in muscle size is dependent on an intact region of FRAIL1 that is highly conserved across non‐human primates. Unbiased transcriptional and proteomic profiling of the effects of FRAIL1 expression in mouse skeletal muscle revealed widespread changes in mRNA and protein abundance that recapitulate age‐related changes in pathways and processes that are known to be altered in aging skeletal muscle. Taken together, these findings shed light on the intricate molecular mechanisms underlying skeletal muscle aging and implicate FRAIL1 in age‐related skeletal muscle phenotypes.